Search Results
Centre for Endocrine and Diabetes Sciences, Department of Medicine, Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Peter Taylor in
Google Scholar
PubMed
Search for other papers by Sandip Bhatt in
Google Scholar
PubMed
Search for other papers by Ravi Gouni in
Google Scholar
PubMed
Search for other papers by Jonathan Quinlan in
Google Scholar
PubMed
Search for other papers by Tony Robinson in
Google Scholar
PubMed
are contraindicated. Case Report A 32-year-old with no clinical risk factors or evidence of pre-existing liver disease was diagnosed with Graves’ disease at week 4 in pregnancy. Her thyroid function tests revealed thyroid-stimulating hormone
Search for other papers by Bernadette Biondi in
Google Scholar
PubMed
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Search for other papers by David S. Cooper in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
defined biochemically by a subnormal serum thyroid-stimulating hormone (TSH) level, with normal levels of free thyroxine (FT 4 ), triiodothyronine (TT 3 ) and/or free triiodothyronine (FT 3 ) [ 1 , 2 , 3 , 4 , 5 , 6 ]. Current assays can detect TSH
Search for other papers by Federica D’Aurizio in
Google Scholar
PubMed
Search for other papers by Alessia Biasotto in
Google Scholar
PubMed
Search for other papers by Claudia Cipri in
Google Scholar
PubMed
Search for other papers by Franco Grimaldi in
Google Scholar
PubMed
Search for other papers by Jessica Zucco in
Google Scholar
PubMed
Search for other papers by Stefania Marzinotto in
Google Scholar
PubMed
Department of Medicine, University of Udine, Udine, Italy
Search for other papers by Francesco Curcio in
Google Scholar
PubMed
Search for other papers by Salvatore Benvenga in
Google Scholar
PubMed
determination is still prone to at least six main types of analytical interference: macro thyroid-stimulating hormone (TSH), heterophilic antibodies, anti-streptavidin antibodies, anti-ruthenium antibodies, biotin and antibodies against triiodothyronine (T3) and
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Search for other papers by Roberto Lorbeer in
Google Scholar
PubMed
Search for other papers by Daniel Tiller in
Google Scholar
PubMed
Search for other papers by Ina Lehmphul in
Google Scholar
PubMed
Search for other papers by Alexander Kluttig in
Google Scholar
PubMed
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Stephan B. Felix in
Google Scholar
PubMed
Search for other papers by Karl Werdan in
Google Scholar
PubMed
Search for other papers by Karin Halina Greiser in
Google Scholar
PubMed
Search for other papers by Josef Köhrle in
Google Scholar
PubMed
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Henry Völzke in
Google Scholar
PubMed
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Marcus Dörr in
Google Scholar
PubMed
is only limited data on the potential linkage between thyroid dysfunction and PAD as one of the major atherosclerotic diseases. One study reported a significantly higher prevalence of increased serum thyroid-stimulating hormone (TSH) concentrations in
Search for other papers by Gerd Krause in
Google Scholar
PubMed
Search for other papers by Anja Eckstein in
Google Scholar
PubMed
Search for other papers by Ralf Schülein in
Google Scholar
PubMed
Introduction TSH-Receptor, Graves’ Disease and Graves’ Orbitopathy The thyrotropin receptor or thyroid-stimulating hormone (TSH) receptor (TSHR) is mainly expressed in follicular epithelial cells of the thyroid gland [ 1 ]. TSHR activation
Search for other papers by Hirosuke Danno in
Google Scholar
PubMed
Search for other papers by Eijun Nishihara in
Google Scholar
PubMed
Search for other papers by Kazuyoshi Kousaka in
Google Scholar
PubMed
Search for other papers by Tomohiko Nakamura in
Google Scholar
PubMed
Search for other papers by Toshihiko Kasahara in
Google Scholar
PubMed
Search for other papers by Takumi Kudo in
Google Scholar
PubMed
Search for other papers by Mitsuru Ito in
Google Scholar
PubMed
Search for other papers by Shuji Fukata in
Google Scholar
PubMed
Search for other papers by Mitsushige Nishikawa in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
]. Materials and Methods Patients This study involved patients who visited our hospital between February 2005 and August 2019. Thyrotoxicosis was diagnosed when the thyroid-stimulating hormone (TSH) concentration was ≤0.1 μU/mL, and FT4 and/or FT3 level
Search for other papers by Beatrice Engelmann in
Google Scholar
PubMed
Search for other papers by Julia Bischof in
Google Scholar
PubMed
Search for other papers by Anne-Luise Dirk in
Google Scholar
PubMed
Search for other papers by Nele Friedrich in
Google Scholar
PubMed
Search for other papers by Elke Hammer in
Google Scholar
PubMed
Search for other papers by Thomas Thiele in
Google Scholar
PubMed
Search for other papers by Dagmar Führer in
Google Scholar
PubMed
Search for other papers by Georg Homuth in
Google Scholar
PubMed
Search for other papers by Georg Brabant in
Google Scholar
PubMed
Search for other papers by Uwe Völker in
Google Scholar
PubMed
.e. thyroid-stimulating hormone (TSH)], free triiodothyronine (fT 3 ) and free thyroxine (fT 4 ) were measured using immunoassays. Sex hormone-binding globulin (SHBG) as well as FIX and FXIII subunit B concentrations were determined in EDTA plasma using a
Search for other papers by Wenxing Guo in
Google Scholar
PubMed
Search for other papers by Long Tan in
Google Scholar
PubMed
Search for other papers by Shuyao Dong in
Google Scholar
PubMed
Search for other papers by Ya Jin in
Google Scholar
PubMed
Search for other papers by Mei Zhu in
Google Scholar
PubMed
Search for other papers by Hongyan Wei in
Google Scholar
PubMed
Search for other papers by Yanting Chen in
Google Scholar
PubMed
Search for other papers by Lili Fan in
Google Scholar
PubMed
Search for other papers by Cong Du in
Google Scholar
PubMed
The Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China
Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, China
Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China
Search for other papers by Wanqi Zhang in
Google Scholar
PubMed
stored in a clean glass tube. Samples were spun and the serum was separated within 2 h from taking the blood sample, and the aliquots were frozen at −20°C until further analysis. The concentrations of thyroid-stimulating hormone (TSH) were measured with
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Laura Croce in
Google Scholar
PubMed
Search for other papers by Fausta Beneventi in
Google Scholar
PubMed
Search for other papers by Federica Ripepi in
Google Scholar
PubMed
Search for other papers by Irene De Maggio in
Google Scholar
PubMed
Search for other papers by Alberto Malovini in
Google Scholar
PubMed
Search for other papers by Camilla Bellingeri in
Google Scholar
PubMed
Search for other papers by Francesca Coperchini in
Google Scholar
PubMed
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Marsida Teliti in
Google Scholar
PubMed
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Mario Rotondi in
Google Scholar
PubMed
Search for other papers by Arsenio Spinillo in
Google Scholar
PubMed
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Flavia Magri in
Google Scholar
PubMed
; TSH, thyroid-stimulating hormone. Evaluation of the potential impact of a TSH value ≥4 mU/L on UtA-PI according to BMI To evaluate the impact of increased TSH on early placentation among women with different BMI we compared the values
Search for other papers by Bushra Shahida in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Tereza Planck in
Google Scholar
PubMed
Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Peter Åsman in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Mikael Lantz in
Google Scholar
PubMed
presence of thyroid-stimulating hormone (TSH)-receptor antibodies (TRAb) and/or diffuse uptake by technetium scintigraphy. GO diagnosis was made by an endocrinologist and/or ophthalmologist based on the presence of clinical signs, as previously described